Perficient: Drug Development

JANUARY 25, 2024

To recap: Part 1 of the series focused on providers This part, Part 2, focuses on payers (insurance companies) Part 3 (by Marlana Voerster ) will focus on medical-device organizations First off: the bad news in trust for payers Gallup’s polling data among U.S.

Nurses 52

Nurses Health Insurance Companies Pharmaceutical Companies Hospitals 52

The Pharma Data

OCTOBER 27, 2020

Under the Affordable Care Act, health insurance companies are required to cover the full cost of any screening test recommended by the U.S. Computer models suggest that about 25 colon cancer deaths are prevented for every 1,000 Americans between 50 and 75 who are screened, Barry said. Preventive Services Task Force (USPSTF).

Health Insurance Companies 52

Health Insurance Companies Doctors Hospitals Science 52

The Pharma Data

NOVEMBER 16, 2020

Yang pointed out that “the fact that it’s generic is a double-edged sword, because no big pharma company is willing to invest a lot of money in developing and marketing a polypill. It may require either health insurance companies or governments or charitable organizations to develop polypills.”

Health Insurance Companies 52

Health Insurance Companies Doctors Medical Schools Pharma Companies 52

Conversations in Drug Development Trends

DECEMBER 12, 2022

While the Genetic Information Nondiscrimination Act (GINA) prohibits discrimination by health insurance companies and employers based on a genetic test result, GINA does not apply to life, long-term care, or disability insurance.

Clinical Trials 52

Clinical Trials Trials Laboratories Research Laboratories 52

The Pharma Data

NOVEMBER 10, 2020

Prior to the passage of the ACA (also known as Obamacare) in March of 2010, health insurance companies routinely denied new coverage — or sometimes charged exorbitant premiums — to people with a prior history of illness.

Health Insurance Companies 52

Health Insurance Companies Research Drugs 52